C
Hologic, Inc.
HOLX
$60.70
-$0.40-0.66%
C
Hold
2/18/2025Downgrade
Hologic, Inc. (HOLX) was downgraded to C- from C on 2/18/2025 due to a noticeable decline in the volatility index, total return index and growth index. Operating cash flow declined 48.42% from $367M to $189.3M, and EBIT declined 1.1% from $236.3M to $233.7M.
Hologic, Inc. (HOLX) was downgraded to C- from C on 2/18/2025 due to a noticeable decline in the volatility index, total return index and growth index. Operating cash flow declined 48.42% from $367M to $189.3M, and EBIT declined 1.1% from $236.3M to $233.7M.
C
Hold
10/7/2024Downgrade
Hologic, Inc. (HOLX) was downgraded to C from C+ on 10/7/2024 due to a decline in the volatility index, growth index and valuation index.
Hologic, Inc. (HOLX) was downgraded to C from C+ on 10/7/2024 due to a decline in the volatility index, growth index and valuation index.
C
Hold
7/31/2024Upgraded
Hologic, Inc. (HOLX) was upgraded to C+ from C on 7/31/2024 due to a major increase in the valuation index, growth index and volatility index. Operating cash flow increased 38.78% from $292.4M to $405.8M, earnings per share increased from $0.72 to $0.82, and EBIT increased 8.47% from $243.3M to $263.9M.
Hologic, Inc. (HOLX) was upgraded to C+ from C on 7/31/2024 due to a major increase in the valuation index, growth index and volatility index. Operating cash flow increased 38.78% from $292.4M to $405.8M, earnings per share increased from $0.72 to $0.82, and EBIT increased 8.47% from $243.3M to $263.9M.
C
Hold
2/5/2024Upgraded
Hologic, Inc. (HOLX) was upgraded to C from C- on 2/5/2024 due to an increase in the volatility index and efficiency index. Net income increased 172.08% from $90.6M to $246.5M.
Hologic, Inc. (HOLX) was upgraded to C from C- on 2/5/2024 due to an increase in the volatility index and efficiency index. Net income increased 172.08% from $90.6M to $246.5M.
C
Hold
11/13/2023Upgraded
Hologic, Inc. (HOLX) was upgraded to C- from D+ on 11/13/2023 due to an increase in the volatility index.
Hologic, Inc. (HOLX) was upgraded to C- from D+ on 11/13/2023 due to an increase in the volatility index.
D
Sell
10/27/2023Downgrade
Hologic, Inc. (HOLX) was downgraded to D+ from C- on 10/27/2023 due to a decline in the volatility index and total return index.
Hologic, Inc. (HOLX) was downgraded to D+ from C- on 10/27/2023 due to a decline in the volatility index and total return index.
C
Hold
10/5/2023Downgrade
Hologic, Inc. (HOLX) was downgraded to C- from C on 10/5/2023 due to a large decline in the volatility index and total return index.
Hologic, Inc. (HOLX) was downgraded to C- from C on 10/5/2023 due to a large decline in the volatility index and total return index.
C
Hold
8/2/2023Downgrade
Hologic, Inc. (HOLX) was downgraded to C from B- on 8/2/2023 due to a significant decline in the growth index, total return index and valuation index. Earnings per share declined from $0.87 to -$0.164, EBIT declined 13.08% from $261.5M to $227.3M, and total revenue declined 4.1% from $1.03B to $984.4M.
Hologic, Inc. (HOLX) was downgraded to C from B- on 8/2/2023 due to a significant decline in the growth index, total return index and valuation index. Earnings per share declined from $0.87 to -$0.164, EBIT declined 13.08% from $261.5M to $227.3M, and total revenue declined 4.1% from $1.03B to $984.4M.
B
Buy
5/4/2023Downgrade
Hologic, Inc. (HOLX) was downgraded to B- from B on 5/4/2023 due to a major decline in the growth index, valuation index and efficiency index. Operating cash flow declined 18.59% from $253.4M to $206.3M, total revenue declined 4.44% from $1.07B to $1.03B, and EBIT declined 0.76% from $263.5M to $261.5M.
Hologic, Inc. (HOLX) was downgraded to B- from B on 5/4/2023 due to a major decline in the growth index, valuation index and efficiency index. Operating cash flow declined 18.59% from $253.4M to $206.3M, total revenue declined 4.44% from $1.07B to $1.03B, and EBIT declined 0.76% from $263.5M to $261.5M.
B
Buy
3/6/2023Upgraded
Hologic, Inc. (HOLX) was upgraded to B from B- on 3/6/2023 due to a substantial increase in the growth index, total return index and solvency index. Earnings per share increased from $0.4743 to $0.75, operating cash flow increased 50.3% from $168.6M to $253.4M, and EBIT increased 47.7% from $178.4M to $263.5M.
Hologic, Inc. (HOLX) was upgraded to B from B- on 3/6/2023 due to a substantial increase in the growth index, total return index and solvency index. Earnings per share increased from $0.4743 to $0.75, operating cash flow increased 50.3% from $168.6M to $253.4M, and EBIT increased 47.7% from $178.4M to $263.5M.
B
Buy
1/23/2023Upgraded
Hologic, Inc. (HOLX) was upgraded to B- from C+ on 1/23/2023 due to a large increase in the total return index, volatility index and efficiency index.
Hologic, Inc. (HOLX) was upgraded to B- from C+ on 1/23/2023 due to a large increase in the total return index, volatility index and efficiency index.
C
Hold
11/8/2022Upgraded
Hologic, Inc. (HOLX) was upgraded to C+ from C on 11/8/2022 due to an increase in the total return index and volatility index.
Hologic, Inc. (HOLX) was upgraded to C+ from C on 11/8/2022 due to an increase in the total return index and volatility index.
C
Hold
10/24/2022Downgrade
Hologic, Inc. (HOLX) was downgraded to C from C+ on 10/24/2022 due to a decline in the volatility index and total return index.
Hologic, Inc. (HOLX) was downgraded to C from C+ on 10/24/2022 due to a decline in the volatility index and total return index.
C
Hold
9/14/2022Downgrade
Hologic, Inc. (HOLX) was downgraded to C+ from B- on 9/14/2022 due to a noticeable decline in the total return index and volatility index.
Hologic, Inc. (HOLX) was downgraded to C+ from B- on 9/14/2022 due to a noticeable decline in the total return index and volatility index.
B
Buy
7/28/2022Downgrade
Hologic, Inc. (HOLX) was downgraded to B- from B on 7/28/2022 due to a large decline in the growth index, total return index and valuation index. Operating cash flow declined 68.87% from $1.06B to $330.7M, EBIT declined 59.84% from $593.9M to $238.5M, and earnings per share declined from $1.8 to $0.9.
Hologic, Inc. (HOLX) was downgraded to B- from B on 7/28/2022 due to a large decline in the growth index, total return index and valuation index. Operating cash flow declined 68.87% from $1.06B to $330.7M, EBIT declined 59.84% from $593.9M to $238.5M, and earnings per share declined from $1.8 to $0.9.
B
Buy
6/29/2022Upgraded
Hologic, Inc. (HOLX) was upgraded to B from B- on 6/29/2022 due to an increase in the volatility index and valuation index.
Hologic, Inc. (HOLX) was upgraded to B from B- on 6/29/2022 due to an increase in the volatility index and valuation index.
B
Buy
6/14/2022Downgrade
Hologic, Inc. (HOLX) was downgraded to B- from B on 6/14/2022 due to a substantial decline in the growth index, valuation index and volatility index. Earnings per share declined from $1.95 to $1.8, EBIT declined 6.82% from $637.4M to $593.9M, and total revenue declined 2.41% from $1.47B to $1.44B.
Hologic, Inc. (HOLX) was downgraded to B- from B on 6/14/2022 due to a substantial decline in the growth index, valuation index and volatility index. Earnings per share declined from $1.95 to $1.8, EBIT declined 6.82% from $637.4M to $593.9M, and total revenue declined 2.41% from $1.47B to $1.44B.
B
Buy
4/25/2022Upgraded
Hologic, Inc. (HOLX) was upgraded to B from B- on 4/25/2022 due to an increase in the total return index, volatility index and solvency index.
Hologic, Inc. (HOLX) was upgraded to B from B- on 4/25/2022 due to an increase in the total return index, volatility index and solvency index.
B
Buy
2/28/2022Upgraded
Hologic, Inc. (HOLX) was upgraded to B- from C+ on 2/28/2022 due to an increase in the volatility index and valuation index.
Hologic, Inc. (HOLX) was upgraded to B- from C+ on 2/28/2022 due to an increase in the volatility index and valuation index.
C
Hold
2/11/2022Downgrade
Hologic, Inc. (HOLX) was downgraded to C+ from B- on 2/11/2022 due to a large decline in the total return index and valuation index.
Hologic, Inc. (HOLX) was downgraded to C+ from B- on 2/11/2022 due to a large decline in the total return index and valuation index.
B
Buy
12/27/2021Downgrade
Hologic, Inc. (HOLX) was downgraded to B- from B on 12/27/2021 due to a noticeable decline in the total return index and valuation index.
Hologic, Inc. (HOLX) was downgraded to B- from B on 12/27/2021 due to a noticeable decline in the total return index and valuation index.
B
Buy
12/9/2021Upgraded
Hologic, Inc. (HOLX) was upgraded to B from B- on 12/9/2021 due to a large increase in the total return index, growth index and efficiency index. EBIT increased 23.03% from $362.2M to $445.6M, earnings per share increased from $1.04 to $1.2746, and net income increased 22.5% from $268.4M to $328.8M.
Hologic, Inc. (HOLX) was upgraded to B from B- on 12/9/2021 due to a large increase in the total return index, growth index and efficiency index. EBIT increased 23.03% from $362.2M to $445.6M, earnings per share increased from $1.04 to $1.2746, and net income increased 22.5% from $268.4M to $328.8M.
B
Buy
6/1/2021Downgrade
Hologic, Inc. (HOLX) was downgraded to B- from B on 6/1/2021 due to a major decline in the total return index, growth index and efficiency index. Operating cash flow declined 15.05% from $650M to $552.2M, EBIT declined 10.54% from $892.5M to $798.4M, and net income declined 5.27% from $654.4M to $619.9M.
Hologic, Inc. (HOLX) was downgraded to B- from B on 6/1/2021 due to a major decline in the total return index, growth index and efficiency index. Operating cash flow declined 15.05% from $650M to $552.2M, EBIT declined 10.54% from $892.5M to $798.4M, and net income declined 5.27% from $654.4M to $619.9M.
B
Buy
11/23/2020Upgraded
Hologic, Inc. (HOLX) was upgraded to B from B- on 11/23/2020 due to a substantial increase in the valuation index, total return index and efficiency index. Net income increased 258.88% from $137.9M to $494.9M, and total capital increased 3.2% from $5.7B to $5.88B.
Hologic, Inc. (HOLX) was upgraded to B from B- on 11/23/2020 due to a substantial increase in the valuation index, total return index and efficiency index. Net income increased 258.88% from $137.9M to $494.9M, and total capital increased 3.2% from $5.7B to $5.88B.
B
Buy
8/25/2020Upgraded
Hologic, Inc. (HOLX) was upgraded to B- from C+ on 8/25/2020 due to an increase in the total return index and volatility index.
Hologic, Inc. (HOLX) was upgraded to B- from C+ on 8/25/2020 due to an increase in the total return index and volatility index.
C
Hold
7/31/2020Upgraded
Hologic, Inc. (HOLX) was upgraded to C+ from C on 7/31/2020 due to a significant increase in the growth index, total return index and solvency index. Operating cash flow increased 89.46% from $117.7M to $223M, earnings per share increased from $0.36 to $0.53, and EBIT increased 20.53% from $159.3M to $192M.
Hologic, Inc. (HOLX) was upgraded to C+ from C on 7/31/2020 due to a significant increase in the growth index, total return index and solvency index. Operating cash flow increased 89.46% from $117.7M to $223M, earnings per share increased from $0.36 to $0.53, and EBIT increased 20.53% from $159.3M to $192M.
C
Hold
5/1/2020Upgraded
Hologic, Inc. (HOLX) was upgraded to C from C- on 5/1/2020 due to a significant increase in the valuation index, efficiency index and solvency index. Total capital increased 6.17% from $5.44B to $5.78B, and the quick ratio increased from 0.91 to 0.94.
Hologic, Inc. (HOLX) was upgraded to C from C- on 5/1/2020 due to a significant increase in the valuation index, efficiency index and solvency index. Total capital increased 6.17% from $5.44B to $5.78B, and the quick ratio increased from 0.91 to 0.94.
C
Hold
3/16/2020Downgrade
Hologic, Inc. (HOLX) was downgraded to C- from C on 3/16/2020 due to a decline in the volatility index and total return index.
Hologic, Inc. (HOLX) was downgraded to C- from C on 3/16/2020 due to a decline in the volatility index and total return index.
C
Hold
2/4/2020Upgraded
Hologic, Inc. (HOLX) was upgraded to C from D+ on 2/4/2020 due to a large increase in the growth index, efficiency index and solvency index. Net income increased 412.63% from -$123.5M to $386.1M, earnings per share increased from -$0.4593 to $1.43, and total capital increased 4.19% from $5.23B to $5.44B.
Hologic, Inc. (HOLX) was upgraded to C from D+ on 2/4/2020 due to a large increase in the growth index, efficiency index and solvency index. Net income increased 412.63% from -$123.5M to $386.1M, earnings per share increased from -$0.4593 to $1.43, and total capital increased 4.19% from $5.23B to $5.44B.
D
Sell
11/29/2019Downgrade
Hologic, Inc. (HOLX) was downgraded to D+ from C on 11/29/2019 due to a significant decline in the growth index, efficiency index and volatility index. Earnings per share declined from $0.3492 to -$0.4593, net income declined 231.52% from $93.9M to -$123.5M, and total capital declined 1.25% from $5.29B to $5.23B.
Hologic, Inc. (HOLX) was downgraded to D+ from C on 11/29/2019 due to a significant decline in the growth index, efficiency index and volatility index. Earnings per share declined from $0.3492 to -$0.4593, net income declined 231.52% from $93.9M to -$123.5M, and total capital declined 1.25% from $5.29B to $5.23B.
C
Hold
8/1/2019Upgraded
Hologic, Inc. (HOLX) was upgraded to C from C- on 8/1/2019 due to a significant increase in the growth index, volatility index and total return index. Earnings per share increased from -$1.0125 to $0.3492, operating cash flow increased 22.62% from $133.5M to $163.7M, and EBIT increased 10.04% from $134.5M to $148M.
Hologic, Inc. (HOLX) was upgraded to C from C- on 8/1/2019 due to a significant increase in the growth index, volatility index and total return index. Earnings per share increased from -$1.0125 to $0.3492, operating cash flow increased 22.62% from $133.5M to $163.7M, and EBIT increased 10.04% from $134.5M to $148M.
C
Hold
5/3/2018Downgrade
Hologic, Inc. (HOLX) was downgraded to C- from C+ on 5/3/2018 due to a significant decline in the valuation index, efficiency index and growth index. Earnings per share declined from $1.45 to -$2.46, net income declined 267.54% from $406.7M to -$681.4M, and operating cash flow declined 42.4% from $169.1M to $97.4M.
Hologic, Inc. (HOLX) was downgraded to C- from C+ on 5/3/2018 due to a significant decline in the valuation index, efficiency index and growth index. Earnings per share declined from $1.45 to -$2.46, net income declined 267.54% from $406.7M to -$681.4M, and operating cash flow declined 42.4% from $169.1M to $97.4M.
C
Hold
4/6/2018Downgrade
Hologic, Inc. (HOLX) was downgraded to C+ from B- on 4/6/2018 due to a noticeable decline in the volatility index, total return index and solvency index.
Hologic, Inc. (HOLX) was downgraded to C+ from B- on 4/6/2018 due to a noticeable decline in the volatility index, total return index and solvency index.
B
Buy
9/27/2017Downgrade
Hologic, Inc. (HOLX) was downgraded to B- from B on 9/27/2017 due to a decline in the volatility index.
Hologic, Inc. (HOLX) was downgraded to B- from B on 9/27/2017 due to a decline in the volatility index.
B
Buy
9/8/2017Upgraded
Hologic, Inc. (HOLX) was upgraded to B from B- on 9/8/2017 due to an increase in the valuation index, solvency index and volatility index.
Hologic, Inc. (HOLX) was upgraded to B from B- on 9/8/2017 due to an increase in the valuation index, solvency index and volatility index.
B
Buy
8/3/2017Downgrade
Hologic, Inc. (HOLX) was downgraded to B- from B on 8/3/2017 due to a significant decline in the growth index, solvency index and volatility index. Operating cash flow declined 591.29% from $83.8M to -$411.7M, earnings per share declined from $1.84 to $0.21, and the quick ratio declined from 0.67 to 0.61.
Hologic, Inc. (HOLX) was downgraded to B- from B on 8/3/2017 due to a significant decline in the growth index, solvency index and volatility index. Operating cash flow declined 591.29% from $83.8M to -$411.7M, earnings per share declined from $1.84 to $0.21, and the quick ratio declined from 0.67 to 0.61.
B
Buy
11/18/2016Upgraded
Hologic Inc. (HOLX) was upgraded to B from C on 11/18/2016 due to a significant increase in the growth index, efficiency index and valuation index. Earnings per share increased from $0.3 to $0.3307, net income increased 8.61% from $84.8M to $92.1M, and EBIT increased 6.05% from $147.1M to $156M.
Hologic Inc. (HOLX) was upgraded to B from C on 11/18/2016 due to a significant increase in the growth index, efficiency index and valuation index. Earnings per share increased from $0.3 to $0.3307, net income increased 8.61% from $84.8M to $92.1M, and EBIT increased 6.05% from $147.1M to $156M.
C
Hold
3/11/2016Downgrade
Hologic Inc. (HOLX) was downgraded to C from C+ on 3/11/2016 due to a significant decline in the volatility index, total return index and valuation index.
Hologic Inc. (HOLX) was downgraded to C from C+ on 3/11/2016 due to a significant decline in the volatility index, total return index and valuation index.
C
Hold
1/29/2016Upgraded
Hologic Inc. (HOLX) was upgraded to C+ from C on 1/29/2016 due to a large increase in the valuation index and efficiency index. Net income increased 238.25% from $25.1M to $84.9M, and total capital increased 0.79% from $5.75B to $5.8B.
Hologic Inc. (HOLX) was upgraded to C+ from C on 1/29/2016 due to a large increase in the valuation index and efficiency index. Net income increased 238.25% from $25.1M to $84.9M, and total capital increased 0.79% from $5.75B to $5.8B.
C
Hold
7/30/2015Downgrade
Hologic Inc. (HOLX) was downgraded to C from C+ on 7/30/2015 due to a large decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.17 to $0.1.
Hologic Inc. (HOLX) was downgraded to C from C+ on 7/30/2015 due to a large decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.17 to $0.1.
C
Hold
5/1/2015Upgraded
Hologic Inc. (HOLX) was upgraded to C+ from C on 5/1/2015 due to a significant increase in the growth index, total return index and solvency index. Earnings per share increased from $0.1 to $0.17, debt to equity declined from 1.88 to 1.82, and operating cash flow increased 2.8% from $153.5M to $157.8M.
Hologic Inc. (HOLX) was upgraded to C+ from C on 5/1/2015 due to a significant increase in the growth index, total return index and solvency index. Earnings per share increased from $0.1 to $0.17, debt to equity declined from 1.88 to 1.82, and operating cash flow increased 2.8% from $153.5M to $157.8M.
C
Hold
7/1/2014Upgraded
Hologic Inc. (HOLX) was upgraded to C from C- on 7/1/2014 due to a major increase in the total return index and volatility index.
Hologic Inc. (HOLX) was upgraded to C from C- on 7/1/2014 due to a major increase in the total return index and volatility index.
C
Hold
5/5/2014Downgrade
Hologic Inc. (HOLX) was downgraded to C- from C on 5/5/2014 due to a major decline in the total return index, growth index and efficiency index. Operating cash flow declined 53.74% from $149.27M to $69.05M.
Hologic Inc. (HOLX) was downgraded to C- from C on 5/5/2014 due to a major decline in the total return index, growth index and efficiency index. Operating cash flow declined 53.74% from $149.27M to $69.05M.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
